Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2007

01.02.2007 | Short Communication

Endothelial nitric oxide synthase gene polymorphisms in non-arteritic anterior ischemic optic neuropathy

verfasst von: Tsutomu Sakai, Keigo Shikishima, Masato Matsushima, Kenji Kitahara

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

To examine the association between the polymorphisms of the endothelial nitric oxide synthase (eNOS) gene and the occurrence of non-arteritic anterior ischemic optic neuropathy (NAION).

Methods

We studied 15 patients with NAION (mean age, 62 years; 60% male). We investigated two polymorphisms of the eNOS gene, Glu298Asp polymorphism of exon 7 and T(–786)C polymorphism of the promoter region. The genotype distribution in NAION was compared with the control (mean age, 63 years; 63% male) distribution.

Results

There was no significant difference in the genotype distribution of the Glu298Asp polymorphism between the NAION and control groups (P=1.000), whereas the genotype distribution of the T(–786)C polymorphism varied significantly between the patients with NAION and control subjects (P=0.002). After adjusting on covariates, individuals with the CC genotype of the T(–786)C polymorphism were more likely to develop NAION compared with those with TT genotype (odds ratio=0.09: 95% CI 0.01–0.86).

Conclusions

We found an increased prevalence of T(–786)C polymorphism of the eNOS gene in patients with NAION. Our data suggest that the T(–786)C polymorphism of the eNOS gene may be an important risk factor in the development of NAION in Japanese subjects.
Literatur
1.
Zurück zum Zitat Beck RW, Gamel JW, Willcourt RJ et al (1980) Acute ischemic optic neuropathy in severe preeclampsia. Am J Ophthalmol 90:342–346PubMed Beck RW, Gamel JW, Willcourt RJ et al (1980) Acute ischemic optic neuropathy in severe preeclampsia. Am J Ophthalmol 90:342–346PubMed
2.
Zurück zum Zitat Boulanger C, Luscher TF (1990) Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587–590PubMed Boulanger C, Luscher TF (1990) Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587–590PubMed
3.
Zurück zum Zitat De Caterina R, Libby P, Peng HB et al (1995) Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60–68PubMedCrossRef De Caterina R, Libby P, Peng HB et al (1995) Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60–68PubMedCrossRef
4.
Zurück zum Zitat Gomma AH, Elrayess MA, Knight CJ et al (2002) The endothelial nitric oxide synthase (Glu298Asp and –786T>C) gene polymorphisms are associated with coronary in–stent restenosis. Eur Heart J 23:1955–1962PubMedCrossRef Gomma AH, Elrayess MA, Knight CJ et al (2002) The endothelial nitric oxide synthase (Glu298Asp and –786T>C) gene polymorphisms are associated with coronary in–stent restenosis. Eur Heart J 23:1955–1962PubMedCrossRef
5.
Zurück zum Zitat Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603–624PubMed Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603–624PubMed
6.
Zurück zum Zitat Hayreh SS (1996) Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations, and management. In: Katz B, ed. Ophthalmology Clinics of North America: transient monocular visual loss. WB Saunders Co., Philadelphia, Pa., pp 407–412 Hayreh SS (1996) Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations, and management. In: Katz B, ed. Ophthalmology Clinics of North America: transient monocular visual loss. WB Saunders Co., Philadelphia, Pa., pp 407–412
7.
Zurück zum Zitat Ischemic Optic Neuropathy Decompression Trial Research Group (1996) Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 114:1366–1374 Ischemic Optic Neuropathy Decompression Trial Research Group (1996) Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 114:1366–1374
8.
Zurück zum Zitat Kim JU, Chang HK, Lee SS et al (2003) Endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease and rheumatic diseases with vasculitis. Ann Rheum Dis 62: 1083–1087PubMedCrossRef Kim JU, Chang HK, Lee SS et al (2003) Endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease and rheumatic diseases with vasculitis. Ann Rheum Dis 62: 1083–1087PubMedCrossRef
9.
Zurück zum Zitat Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651–4655PubMedCrossRef Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651–4655PubMedCrossRef
10.
Zurück zum Zitat Lessell S (1999) Nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 117:386–388PubMed Lessell S (1999) Nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 117:386–388PubMed
11.
Zurück zum Zitat Nakayama M, Yasue H, Yoshimura M et al (1999) T–786→C mutation in the 5′–flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864–2870PubMed Nakayama M, Yasue H, Yoshimura M et al (1999) T–786→C mutation in the 5′–flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864–2870PubMed
12.
Zurück zum Zitat Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526PubMedCrossRef Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526PubMedCrossRef
13.
Zurück zum Zitat Potarazu SV (1997) Ischemic optic neuropathy: models for mechanism of disease. Clin Neurosci 4:264–269PubMed Potarazu SV (1997) Ischemic optic neuropathy: models for mechanism of disease. Clin Neurosci 4:264–269PubMed
14.
Zurück zum Zitat Radmoski MW, Palmer RM, Moncada S (1987). Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057–1058CrossRef Radmoski MW, Palmer RM, Moncada S (1987). Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057–1058CrossRef
15.
Zurück zum Zitat Radmoski MW, Palmer RM, Moncada S (1990) Characterization of the l-arginine:nitric oxide pathway in human platelets. Br J Pharmacol 101:325–328 Radmoski MW, Palmer RM, Moncada S (1990) Characterization of the l-arginine:nitric oxide pathway in human platelets. Br J Pharmacol 101:325–328
16.
Zurück zum Zitat Rossi GP, Cesari M, Zanchetta M et al (2003) The T–786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41:930–937PubMedCrossRef Rossi GP, Cesari M, Zanchetta M et al (2003) The T–786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41:930–937PubMedCrossRef
17.
Zurück zum Zitat Salvarani C, Casali B, Nicoli D et al (2003) Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthr Rheum 48:3219–3223PubMedCrossRef Salvarani C, Casali B, Nicoli D et al (2003) Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthr Rheum 48:3219–3223PubMedCrossRef
18.
Zurück zum Zitat Shimasaki Y, Yasue H, Yoshimura M et al (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31:1506–1510PubMedCrossRef Shimasaki Y, Yasue H, Yoshimura M et al (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31:1506–1510PubMedCrossRef
19.
Zurück zum Zitat Takemoto M, Egashira K, Usui M et al (1997) Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99:278–287PubMed Takemoto M, Egashira K, Usui M et al (1997) Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99:278–287PubMed
20.
Zurück zum Zitat Tsujita Y, Baba S, Yamauchi R et al (2001) Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita study. J Hypertens 19:1941–1948PubMedCrossRef Tsujita Y, Baba S, Yamauchi R et al (2001) Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita study. J Hypertens 19:1941–1948PubMedCrossRef
21.
Zurück zum Zitat Yamada Y, Izawa H, Ichihara S, Takatsu, Ishihara, Hirayama H, Sone T, Tanaka M, Yokota M (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916–1923PubMedCrossRef Yamada Y, Izawa H, Ichihara S, Takatsu, Ishihara, Hirayama H, Sone T, Tanaka M, Yokota M (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916–1923PubMedCrossRef
22.
Zurück zum Zitat Yoshimura M, Yasue H, Nakayama M et al (2000) Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T–786→C and missense Glu298Asp variants. J Invest Med 48:367–374 Yoshimura M, Yasue H, Nakayama M et al (2000) Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T–786→C and missense Glu298Asp variants. J Invest Med 48:367–374
Metadaten
Titel
Endothelial nitric oxide synthase gene polymorphisms in non-arteritic anterior ischemic optic neuropathy
verfasst von
Tsutomu Sakai
Keigo Shikishima
Masato Matsushima
Kenji Kitahara
Publikationsdatum
01.02.2007
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2007
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-005-0245-7

Weitere Artikel der Ausgabe 2/2007

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2007 Zur Ausgabe

Announcements

Announcements

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.